When David Callahan, Inside Philanthropy’s founder, was unable to attend the Pershing Square Foundation’s recent 10th-anniversary gala, he conscripted me to go in his stead. He told me the foundation, started by the hedge funder Bill Ackman and his wife Karen, is one of the more interesting new funders to emerge from the finance world … Continued
… Commitments have risen and fallen with his funds’ performance, but the foundation has pledged a total of about $400 million since inception and generated plenty of success stories that were shared at the group’s 10th anniversary celebration. Frederick Wiseman thanked Ackman for supporting his documentaries like the one on the New York Public Library … Continued
Governments around the world have increasingly turned to behavioral science to help address various policy problems – new research shows that some of the best-known strategies derived from behavioral science, commonly referred to as ‘nudges,’ may be extremely cost effective. The new study, which examined the cost-effectiveness of nudges and typical intervention strategies like financial … Continued
President Donald Trump’s 2018 budget isn’t kind to science funding, but Bill Ackman is. One day after Congress received the administration’s request to cut almost $6 billion from the National Institutes of Health, the hedge fund manager and his philanthropic team awarded six scientists $200,000 a year each, for up to three years. The fourth … Continued
By David Callahan and Kiersten Marek (Inside Philanthropy) – Two years ago, we published a list of the 15 most powerful women in U.S. philanthropy. The idea for that article emerged because we were struck by how many women are involved in philanthropy at a high level
By Paula Goldman (Harvard Business Review) – Andrew Carnegie’s advice in the 1889 essay “Wealth” was to spend the first part of your life getting as much education as possible, to spend the second part making all the money you could, and to spend the last part giving it all away for worthwhile causes.
By Eric S. Lander (Cell) – Three years ago, scientists reported that CRISPR technology can enable precise and efficient genome editing in living eukaryotic cells. Since then, the method has taken the scientific community by storm, with thousands of labs using it for applications from biomedicine to agriculture.